Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.
about
Advancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass SpectrometerDoes the biomarker search paradigm need re-booting?Urine collection and processing for protein biomarker discovery and quantification.Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.Application of proteomics to cancer early detectionIdentification of cystatin SA as a novel inhibitor of acid ceramidase.Bladder cancer determination via two urinary metabolites: a biomarker pattern approachThe increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.High levels of cathepsin D and cystatin B are associated with increased risk of coronary events.Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection.The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer.Bladder cancer detection and monitoring: assessment of urine- and blood-based marker testsTen Years of Proteomics in Bladder Cancer: Progress and Future Directions.Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.Noninvasive approaches for detecting and monitoring bladder cancer.Developing proteomic biomarkers for bladder cancer: towards clinical application.Emerging role of Hippo signalling pathway in bladder cancer.Proteomics applied to pediatric medicine: opportunities and challenges.A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder CancerDivergent synthesis and identification of the cellular targets of deoxyelephantopins.Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model.Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma.Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
P2860
Q30999645-1D12A3ED-1B35-414C-8102-489023730F03Q33413444-354EA398-74F7-4398-ACC5-CB3603F13642Q33780855-FBD16096-0A07-42B3-864B-52DD714AD1F2Q33881201-67E62131-8849-419B-BD99-553BE7BC68D9Q35053031-A090F54E-78C9-4DA2-B842-228673DC2AD2Q35371286-65A29D51-79C9-4F0E-B5D7-558804FEE8E0Q35497484-92FB6CB0-37FE-4F20-BA24-DA363E90D4BEQ36019595-36B1D6F8-528B-47C1-B12D-1D1A7185FEE3Q36190604-AEBC9D9C-74E8-4DC6-A259-7EE215613506Q36517244-92C859D4-585E-4593-A639-3D3C4DFAC071Q36615746-6AD6E35E-DEF5-40D4-AF91-5C62F99CCFD8Q36752744-8CBDA7E2-019E-495B-8A05-1A3C5E0BD837Q36770389-746C756A-64B6-47A1-A599-4EDDA1DD99C0Q37610542-A5B7D407-8534-4D3E-9CE6-AD4A5F5CDE2BQ37688671-EA0EA94B-5033-496A-8675-56BBC62065F1Q37818317-FE4B10D5-3E51-4065-A3A3-FD849775FEB5Q38286089-98767901-22C2-4F53-BA96-733E5742AAF4Q38511509-4ACA00A6-ECD9-412F-AAFA-8CBCBA3C9A4BQ38637679-38EE35A5-F530-4CDD-B1AF-8C6617B2093CQ38833713-722A44AB-AA4D-4B12-92D4-6D569AAEC4BBQ38921522-E5CDB3A2-2E5F-4591-BF63-0F1D07CA29C9Q41504689-08320C3E-8AE8-4C07-9666-F0621748DF3AQ42275957-0965D7FF-F9AC-4952-B6B3-6A01A29CE20DQ47826917-3A7633BE-8A91-43AB-8B2E-FBE30EE453B6Q58763470-DA7399BA-B11C-450E-B37C-217140FC8FA4
P2860
Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cystatin B as a tissue and uri ...... rence and disease progression.
@en
Cystatin B as a tissue and uri ...... rence and disease progression.
@nl
type
label
Cystatin B as a tissue and uri ...... rence and disease progression.
@en
Cystatin B as a tissue and uri ...... rence and disease progression.
@nl
prefLabel
Cystatin B as a tissue and uri ...... rence and disease progression.
@en
Cystatin B as a tissue and uri ...... rence and disease progression.
@nl
P2093
P2860
P1476
Cystatin B as a tissue and uri ...... rence and disease progression.
@en
P2093
Adam S Feldman
Bruce R Zetter
Chin-Lee Wu
Jacqueline Banyard
W Scott McDougal
P2860
P304
P356
10.1158/1078-0432.CCR-08-1143
P407
P577
2009-02-01T00:00:00Z